Key Methotrexate Drugs Market Players:
- Hikma Pharmaceuticals PLC (UK)
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Pfizer Inc. (U.S.)
- Fresenius Kabi AG (Germany)
- Viatris Inc. (U.S.)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Mylan N.V. (Now part of Viatris) (U.S.)
- Dr. Reddy's Laboratories Ltd. (India)
- Sun Pharmaceutical Industries Ltd. (India)
- Novartis AG (Sandoz) (Switzerland)
- Accord Healthcare Ltd. (UK)
- Sintetica SA (Switzerland)
- Medac GmbH (Germany)
- Shanghai Pharmaceuticals Holding Co., Ltd. (China)
- Kwizda Pharma GmbH (Austria)
- RPG Life Sciences Ltd. (India)
The international methotrexate drugs market is effectively dominated and fragmented by already established generic pharmaceutical manufacturers. Competition in the market is initially based on affordability, regulatory compliance, and supply chain dependency, in comparison to product advancements. Besides, suitable and tactical strategies, such as vertical integration to successfully control API supply and combat shortage risks, have been clearly seen in Fresenius Kabi and Hikma Pharmaceuticals. Meanwhile, organizations, such as Viatris and Pfizer, have leveraged their massive international distribution networks to achieve tenders in public health systems, thereby suitable for boosting the market globally.
Here is a list of key players operating in the global market:
